Skip to main content



Our new and innovative chromatographic immunoassay technology called Dual Path Platform (DPP®) is ideal for rapid, point-of-care diagnostic testing of a wide variety of analytes.

Learn more


10 U.S. Patents Issued, 14 U.S. Patent Applications, 11 International Patents Issued, 6 International Patents Pending

Learn more


Find a list of journal articles referencing our point-of-care tests and technology.

Learn more

We are looking for talented, dedicated people wishing to contribute to our common vision of enhancing the health and well being of people worldwide.

Subscribe to the Chembio Mailing List